Harpoon Therapeutics, Inc. (HARP): Price and Financial Metrics

Harpoon Therapeutics, Inc. (HARP): $2.08

0.11 (+5.58%)

POWR Rating

Component Grades













Add HARP to Watchlist
Sign Up

Industry: Biotech



in industry

HARP Stock Price Chart Interactive Chart >

Price chart for HARP

HARP Price/Volume Stats

Current price $2.08 52-week high $22.74
Prev. close $1.97 52-week low $1.73
Day low $1.89 Volume 271,700
Day high $2.12 Avg. volume 320,686
50-day MA $3.23 Dividend yield N/A
200-day MA $5.85 Market Cap 68.81M

Harpoon Therapeutics, Inc. (HARP) Company Bio

Harpoon Therapeutics, Inc. develops antibody therapies to treat cancer patients. It develops a novel class of T cell recruiting antibodies against validated hematologic and solid tumor targets. The company founded by Patrick A. Baeuerle and Luke B. Evnin in 2015 and is headquartered in South San Francisco, CA.

HARP Latest News Stream

Event/Time News Detail
Loading, please wait...

HARP Latest Social Stream

Loading social stream, please wait...

View Full HARP Social Stream

Latest HARP News From Around the Web

Below are the latest news stories about Harpoon Therapeutics Inc that investors may wish to consider to help them evaluate HARP as an investment opportunity.

Harpoon Therapeutics: A First Look

He who will do anything to avoid failure will almost certainly do something worthy of a failure." -Ryan Holiday” Today, we take an in-depth look at a small developmental firm to determine if it might be worth an investment after a recent large sell-off. Our analysis follows in the paragraphs...

Busted IPO Forum on Seeking Alpha | September 16, 2020

Read More 'HARP' Stories Here

HARP Price Returns

1-mo -7.56%
3-mo -49.27%
6-mo -66.12%
1-year -89.91%
3-year -82.92%
5-year N/A
YTD -72.45%
2021 -54.55%
2020 12.31%
2019 N/A
2018 N/A
2017 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.431 seconds.